Covered recipient · General Payments record
MAKINI SG AINSWORTH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,461.84
- Reported across 192 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $520.84 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $148.17 | 7 |
| PFIZER INC. | $70.53 | 3 |
| Lilly USA, LLC | $67.97 | 3 |
| Abbott Laboratories | $62.58 | 3 |
| EISAI INC. | $41.84 | 2 |
| Acerta Pharma LLC | $38.20 | 2 |
| Azurity Pharmaceuticals, Inc. | $33.77 | 2 |
| Amgen Inc. | $33.27 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $24.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.53 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124906504 | CMS |
| Abbott Laboratories | $19.90 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124906506 | CMS |
| Abbott Laboratories | $23.15 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124906508 | CMS |
| Amgen Inc. | $15.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186072 | CMS |
| Amgen Inc. | $17.68 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186074 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.70 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105828757 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.50 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104681389 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.13 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134002132 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.64 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134002134 | CMS |
| Boston Scientific Corporation | $24.51 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092343436 | CMS |
| Eisai Inc. | $22.00 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110762275 | CMS |
| Eisai Inc. | $19.84 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110762277 | CMS |
| Lilly USA, LLC | $19.08 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135103157 | CMS |
| Lilly USA, LLC | $23.93 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135103159 | CMS |
| Lilly USA, LLC | $24.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135163411 | CMS |
| Novo Nordisk Inc | $16.23 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096734931 | CMS |
| Novo Nordisk Inc | $21.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096813988 | CMS |
| Novo Nordisk Inc | $16.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097207309 | CMS |
| Novo Nordisk Inc | $18.35 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096961962 | CMS |
| Novo Nordisk Inc | $27.17 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096982657 | CMS |
| Novo Nordisk Inc | $29.39 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097431891 | CMS |
| Novo Nordisk Inc | $19.57 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097052859 | CMS |
| PFIZER INC. | $24.17 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131431058 | CMS |
| PFIZER INC. | $21.24 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131754960 | CMS |
| PFIZER INC. | $25.12 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132131619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.